Bill Text: IL HB5156 | 2017-2018 | 100th General Assembly | Introduced
Bill Title: Amends the Nurse Practice Act. In provisions concerning written collaborative agreements, restores the ability of podiatric physicians to collaborate with advanced practice registered nurses. Makes other changes. Effective immediately.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Failed) 2019-01-08 - Session Sine Die [HB5156 Detail]
Download: Illinois-2017-HB5156-Introduced.html
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||||
4 | Section 5. The Nurse Practice Act is amended by changing | |||||||||||||||||||||
5 | Sections 65-35.1 and 65-40 as follows:
| |||||||||||||||||||||
6 | (225 ILCS 65/65-35.1) | |||||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2028) | |||||||||||||||||||||
8 | Sec. 65-35.1. Written collaborative agreement; temporary | |||||||||||||||||||||
9 | practice. Any advanced practice registered nurse required to | |||||||||||||||||||||
10 | enter into a written collaborative agreement with a | |||||||||||||||||||||
11 | collaborating physician or collaborating podiatrist is | |||||||||||||||||||||
12 | authorized to continue to practice for up to 90 days after the | |||||||||||||||||||||
13 | termination of a collaborative agreement provided the advanced | |||||||||||||||||||||
14 | practice registered nurse seeks any needed collaboration at a | |||||||||||||||||||||
15 | local hospital and refers patients who require services beyond | |||||||||||||||||||||
16 | the training and experience of the advanced practice registered | |||||||||||||||||||||
17 | nurse to a physician or other health care provider.
| |||||||||||||||||||||
18 | (Source: P.A. 99-173, eff. 7-29-15; 100-513, eff. 1-1-18 .)
| |||||||||||||||||||||
19 | (225 ILCS 65/65-40)
(was 225 ILCS 65/15-20)
| |||||||||||||||||||||
20 | (Section scheduled to be repealed on January 1, 2028)
| |||||||||||||||||||||
21 | Sec. 65-40. Written collaborative agreement; prescriptive | |||||||||||||||||||||
22 | authority.
|
| |||||||
| |||||||
1 | (a) A collaborating
physician or podiatric physician may, | ||||||
2 | but is not required to, delegate
prescriptive authority to an | ||||||
3 | advanced practice registered
nurse as part of a written | ||||||
4 | collaborative agreement. This authority may, but is
not | ||||||
5 | required to, include
prescription of, selection of, orders for, | ||||||
6 | administration of, storage of, acceptance of samples of, and | ||||||
7 | dispensing over the counter medications, legend drugs, medical | ||||||
8 | gases, and controlled
substances categorized as
any Schedule | ||||||
9 | III through V controlled substances, as defined in Article II | ||||||
10 | of the
Illinois Controlled Substances Act, and other | ||||||
11 | preparations, including, but not limited to, botanical and | ||||||
12 | herbal remedies. The collaborating physician or podiatric | ||||||
13 | physician must have a valid current Illinois controlled | ||||||
14 | substance license and federal registration to delegate | ||||||
15 | authority to prescribe delegated controlled substances.
| ||||||
16 | (b) To prescribe controlled
substances under this Section, | ||||||
17 | an advanced practice registered
nurse must obtain a mid-level | ||||||
18 | practitioner controlled substance license.
Medication orders | ||||||
19 | shall be
reviewed
periodically by the collaborating physician | ||||||
20 | or podiatric physician .
| ||||||
21 | (c) The collaborating physician or podiatric physician o | ||||||
22 | shall file with the
Department and the Prescription Monitoring | ||||||
23 | Program notice of delegation of prescriptive authority
and
| ||||||
24 | termination of such delegation, in accordance with rules of the | ||||||
25 | Department.
Upon receipt of this notice delegating authority to | ||||||
26 | prescribe any Schedule III through V controlled substances, the |
| |||||||
| |||||||
1 | licensed advanced practice registered nurse shall be
eligible | ||||||
2 | to register for a mid-level practitioner controlled substance | ||||||
3 | license
under Section 303.05 of the Illinois Controlled | ||||||
4 | Substances Act.
| ||||||
5 | (d) In addition to the requirements of subsections (a), | ||||||
6 | (b), and (c) of this Section, a collaborating physician or | ||||||
7 | podiatric physician may, but is not required to, delegate | ||||||
8 | authority to an advanced practice registered nurse to prescribe | ||||||
9 | any Schedule II controlled substances, if all of the following | ||||||
10 | conditions apply: | ||||||
11 | (1) Specific Schedule II controlled substances by oral | ||||||
12 | dosage or topical or transdermal application may be | ||||||
13 | delegated, provided that the delegated Schedule II | ||||||
14 | controlled substances are routinely prescribed by the | ||||||
15 | collaborating physician or podiatric physician . This | ||||||
16 | delegation must identify the specific Schedule II | ||||||
17 | controlled substances by either brand name or generic name. | ||||||
18 | Schedule II controlled substances to be delivered by | ||||||
19 | injection or other route of administration may not be | ||||||
20 | delegated. | ||||||
21 | (2) Any delegation must be controlled substances that | ||||||
22 | the collaborating physician or podiatric physician | ||||||
23 | prescribes. | ||||||
24 | (3) Any prescription must be limited to no more than a | ||||||
25 | 30-day supply, with any continuation authorized only after | ||||||
26 | prior approval of the collaborating physician or podiatric |
| |||||||
| |||||||
1 | physician . | ||||||
2 | (4) The advanced practice registered nurse must | ||||||
3 | discuss the condition of any patients for whom a controlled | ||||||
4 | substance is prescribed monthly with the delegating | ||||||
5 | physician. | ||||||
6 | (5) The advanced practice registered nurse meets the | ||||||
7 | education requirements of Section 303.05 of the Illinois | ||||||
8 | Controlled Substances Act.
| ||||||
9 | (e) Nothing in this Act shall be construed to limit the | ||||||
10 | delegation of tasks
or duties by a physician to a licensed | ||||||
11 | practical nurse, a registered
professional nurse, or other | ||||||
12 | persons. Nothing in this Act shall be construed to limit the | ||||||
13 | method of delegation that may be authorized by any means, | ||||||
14 | including, but not limited to, oral, written, electronic, | ||||||
15 | standing orders, protocols, guidelines, or verbal orders.
| ||||||
16 | (f) Nothing in this Section shall be construed to apply to | ||||||
17 | any medication authority including Schedule II controlled | ||||||
18 | substances of an advanced practice registered nurse for care | ||||||
19 | provided in a hospital, hospital affiliate, or ambulatory | ||||||
20 | surgical treatment center pursuant to Section 65-45. | ||||||
21 | (g) ( Blank ). | ||||||
22 | (h) Nothing in this Section shall be construed to prohibit | ||||||
23 | generic substitution. | ||||||
24 | (i) Nothing in this Section shall be construed to apply to | ||||||
25 | an advanced practice registered nurse who meets the | ||||||
26 | requirements of Section 65-43. |
| |||||||
| |||||||
1 | (Source: P.A. 100-513, eff. 1-1-18 .)
|